# Valbiotis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/valbiotis

- Industry: Biotechnology
- Headquarters: France
- Website: www.valbiotis.com
- Total disclosed funding: $1M
- Latest round: Series C (May 20, 2016)
- Investors on record: 2

## About

Based in France, Valbiotis develops health-focused dietary supplements using plant-based ingredients, targeting consumers seeking natural solutions for cholesterol, metabolic health, and cardiovascular well-being.Founded in 2014 in La Rochelle, France, Valbiotis specializes in dietary supplements aimed at health and well-being. The company has successfully closed 7 funding deals, with the latest round being a VENTURE DEBT of EUR 1.250 mn from Bpifrance. To date, Valbiotis has raised a total of EUR 9.700 mn. The CEO, Sébastien PELTIER, has led the firm through its significant growth phases.Valbiotis focuses on the formulation and distribution of dietary supplements, including Valbiotis® Pro Cholesterol, utilizing Lipidrive® for cholesterol regulation, Valbiotis Pro® Cardio-circulation with Tensodrive® for circulatory health, and Valbiotis® Pro Metabolic Health featuring Totum®63 for blood sugar management. Their products cater to health-conscious consumers and healthcare professionals, primarily in European markets, with aspirations for global expansion.In 2022, Valbiotis reported revenue of EUR 513,247.50 with an EBITDA of EUR -12,529,922.80. The company's revenue model includes direct-to-consumer sales through online platforms and retail, with product pricing ranging from EUR 10.95 to EUR 39.95, facilitating a sustainable relationship with customers.Valbiotis is actively working on new product launches aimed at enhancing its dietary supplement portfolio. The company plans to expand its market presence beyond Europe, targeting specific regions by 2025. Recent funding will be allocated to bolster product development and market entry strategies, ensuring readiness to meet increasing consumer demand.

## Funding rounds

- Series C, May 20, 2016, $1M — Sofimac Partners, Nestadio

## Investors

- Sofimac Partners (https://capitalatlas.ai/funds/sofimac-partners) — Series C
- Nestadio — Series C